Literature DB >> 9632816

PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of PEX12p.

K Okumoto1, N Shimozawa, A Kawai, S Tamura, T Tsukamoto, T Osumi, H Moser, R J Wanders, Y Suzuki, N Kondo, Y Fujiki.   

Abstract

Rat PEX12 cDNA was isolated by functional complementation of peroxisome deficiency of a mutant CHO cell line, ZP109 (K. Okumoto, A. Bogaki, K. Tateishi, T. Tsukamoto, T. Osumi, N. Shimozawa, Y. Suzuki, T. Orii, and Y. Fujiki, Exp. Cell Res. 233:11-20, 1997), using a transient transfection assay and an ectopic, readily visible marker, green fluorescent protein. This cDNA encodes a 359-amino-acid membrane protein of peroxisomes with two transmembrane segments and a cysteine-rich zinc finger, the RING motif. A stable transformant of ZP109 with the PEX12 was morphologically and biochemically restored for peroxisome biogenesis. Pex12p was shown by expression of bona fide as well as epitope-tagged Pex12p to expose both N- and C-terminal regions to the cytosol. Fibroblasts derived from patients with the peroxisome deficiency Zellweger syndrome of complementation group III (CG-III) were also complemented for peroxisome biogenesis with PEX12. Two unrelated patients of this group manifesting peroxisome deficiency disorders possessed homozygous, inactivating PEX12 mutations: in one, Arg180Thr by one point mutation, and in the other, deletion of two nucleotides in codons for 291Asn and 292Ser, creating an apparently unchanged codon for Asn and a codon 292 for termination. These results indicate that the gene encoding peroxisome assembly factor Pex12p is a pathogenic gene of CG-III peroxisome deficiency. Moreover, truncation and site mutation studies, including patient PEX12 analysis, demonstrated that the cytoplasmically oriented N- and C-terminal parts of Pex12p are essential for biological function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632816      PMCID: PMC109016          DOI: 10.1128/MCB.18.7.4324

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Newly identified Chinese hamster ovary cell mutants defective in peroxisome biogenesis represent two novel complementation groups in mammals.

Authors:  K Tateishi; K Okumoto; N Shimozawa; T Tsukamoto; T Osumi; Y Suzuki; N Kondo; I Okano; Y Fujiki
Journal:  Eur J Cell Biol       Date:  1997-08       Impact factor: 4.492

Review 2.  Molecular defects in genetic diseases of peroxisomes.

Authors:  Y Fujiki
Journal:  Biochim Biophys Acta       Date:  1997-10-24

3.  PEX12 encodes an integral membrane protein of peroxisomes.

Authors:  K Okumoto; Y Fujiki
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

4.  Isolation and characterization of peroxisome-deficient Chinese hamster ovary cell mutants representing human complementation group III.

Authors:  K Okumoto; A Bogaki; K Tateishi; T Tsukamoto; T Osumi; N Shimozawa; Y Suzuki; T Orii; Y Fujiki
Journal:  Exp Cell Res       Date:  1997-05-25       Impact factor: 3.905

5.  Peroxisome targeting signal type 1 (PTS1) receptor is involved in import of both PTS1 and PTS2: studies with PEX5-defective CHO cell mutants.

Authors:  H Otera; K Okumoto; K Tateishi; Y Ikoma; E Matsuda; M Nishimura; T Tsukamoto; T Osumi; K Ohashi; O Higuchi; Y Fujiki
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

6.  Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders.

Authors:  C C Chang; W H Lee; H Moser; D Valle; S J Gould
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor.

Authors:  A M Motley; E H Hettema; E M Hogenhout; P Brites; A L ten Asbroek; F A Wijburg; F Baas; H S Heijmans; H F Tabak; R J Wanders; B Distel
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

8.  Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor.

Authors:  P E Purdue; J W Zhang; M Skoneczny; P B Lazarow
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

9.  Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders.

Authors:  H Portsteffen; A Beyer; E Becker; C Epplen; A Pawlak; W H Kunau; G Dodt
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

10.  Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders.

Authors:  B E Reuber; E Germain-Lee; C S Collins; J C Morrell; R Ameritunga; H W Moser; D Valle; S J Gould
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

View more
  19 in total

Review 1.  Disorders related to peroxisomal membranes.

Authors:  J Gärtner
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

2.  Stress induces peroxisome biogenesis genes.

Authors:  E Lopez-Huertas; W L Charlton; B Johnson; I A Graham; A Baker
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

Review 3.  Peroxisomal disorders: clinical, biochemical, and molecular aspects.

Authors:  R J Wanders
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

4.  Two proteases, trypsin domain-containing 1 (Tysnd1) and peroxisomal lon protease (PsLon), cooperatively regulate fatty acid β-oxidation in peroxisomal matrix.

Authors:  Kanji Okumoto; Yukari Kametani; Yukio Fujiki
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

5.  Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation.

Authors:  Masafumi Noguchi; Masanori Honsho; Yuichi Abe; Ryusuke Toyama; Hajime Niwa; Yoshiteru Sato; Kamran Ghaedi; Ali Rahmanifar; Yousef Shafeghati; Yukio Fujiki
Journal:  J Hum Genet       Date:  2014-05-22       Impact factor: 3.172

6.  Hsp70 regulates the interaction between the peroxisome targeting signal type 1 (PTS1)-receptor Pex5p and PTS1.

Authors:  T Harano; S Nose; R Uezu; N Shimizu; Y Fujiki
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

7.  Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders.

Authors:  C C Chang; S J Gould
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

8.  Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D.

Authors:  M Honsho; S Tamura; N Shimozawa; Y Suzuki; N Kondo; Y Fujiki
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

9.  Unique requirements for mono- and polyubiquitination of the peroxisomal targeting signal co-receptor, Pex20.

Authors:  Xueqian Liu; Suresh Subramani
Journal:  J Biol Chem       Date:  2013-01-23       Impact factor: 5.157

10.  The peroxisomal membrane protein import receptor Pex3p is directly transported to peroxisomes by a novel Pex19p- and Pex16p-dependent pathway.

Authors:  Takashi Matsuzaki; Yukio Fujiki
Journal:  J Cell Biol       Date:  2008-12-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.